How can we manage CLL without worsening patients’ quality of life?
EBMT 2016 presentations overview: GvHD and metabolic syndrome
The management of transaminitis in patients receiving idelalisib
How to manage AML in pregnancy
iwCLL 2017 program: the biology of CLL, treatment options and the relapsed/refractory setting